MSN Labs ties up with Eli Lilly for baricitinib in India

As part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow (Oseltamivir) as 75 mg capsules.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eIGK7W
via IFTTT